Reference
Iwasa E, et al. Interstitial Lung Disease as an Adverse Drug Reaction in Japan: Exploration of Regulatory Actions as a Basis for High Reporting. Drug Safety : 2 Jul 2020. Available from: URL: https://doi.org/10.1007/s40264-020-00968-7
Rights and permissions
About this article
Cite this article
Drug-related interstitial lung disease in Japan. Reactions Weekly 1812, 7 (2020). https://doi.org/10.1007/s40278-020-80486-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-80486-5